Moneycontrol PRO

business

Buy BOI, Aurobindo Pharma, Alembic Pharma, Arvind: Kant

Dharmesh Kant of India Nivesh Securities recommends buying Bank of India with a target of Rs 230 and Aurobindo Pharma with a target of Rs 320.

first published: Dec 3, 2013 12:56 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347